Search Results - "Stigliano, R."

Refine Results
  1. 1

    Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC by Stigliano, R, Marelli, L, Yu, D, Davies, N, Patch, D, Burroughs, A K

    Published in Cancer treatment reviews (01-08-2007)
    “…Tumour biopsy is usually considered mandatory for patient management by oncologists. Currently percutaneous ablation is used therapeutically for cirrhotic…”
    Get full text
    Journal Article
  2. 2

    Statin therapy: improving survival in patients with hepatocellular carcinoma and portal hypertension is possible? by Dispinzieri, G, Becchetti, C, Mazzarelli, C, Airoldi, A, Aprile, F, Cesarini, L, Cucco, M, Perricone, G, Stigliano, R, Vangeli, M, Viganò, R, Belli, L S

    Published in Acta gastro-enterologica belgica (01-07-2024)
    “…Statins are generally known for their lipid-lowering properties and protection against cardiovascular events. However, growing evidence suggests that statins…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Tumour Size and Differentiation in Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation: External Validation of a New Prognostic Score by Marelli, L., Grasso, A., Pleguezuelo, M., Martines, H., Stigliano, R., Dhillon, A. P., Patch, D., Davidson, B. R., Sharma, D., Rolles, K., Burroughs, A. K.

    Published in Annals of surgical oncology (01-12-2008)
    “…Background A new prognostic score including tumour differentiation—establishing two groups of patients: group A with >3 points and group B with >4…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? by Stigliano, R, Marelli, L, Yu, D, Davies, N, Patch, D, Burroughs, A.K

    Published in Cancer treatment reviews (01-08-2007)
    “…Summary Background : Tumour biopsy is usually considered mandatory for patient management by oncologists. Currently percutaneous ablation is used…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Liver transplantation and recurrent hepatocellular carcinoma : Predictive value of nodule size in a retrospective and explant study by GRASSO, Alessandro, STIGLIANO, Rosa, MORISCO, Filomena, MARTINES, Hugo, QUAGLIA, Alberto, DHILLON, Amar P, PATCH, David, DAVIDSON, Brian R, ROLLES, Keith, BURROUGHS, Andrew K

    Published in Transplantation (15-06-2006)
    “…Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains a major cause of post-LT death. To assess which preoperative and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Liver transplantation and hepatitis C virus: systematic review of antiviral therapy by Triantos, Christos, Samonakis, Dimitrios, Stigliano, Rosa, Thalheimer, Ulrich, Patch, David, Burroughs, Andrew

    Published in Transplantation (15-02-2005)
    “…Antiviral therapy for recurrent hepatitis C after liver transplantation is increasingly used. This systematic review presents both viral and histological…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20